Therapeutic targeting of interleukin-1 receptor-associated kinase 4 (IRAK4) in cancers characterized by rearrangements in the mixed lineage leukemia gene (MLL-r)

  • US 10,640,502 B2
  • Filed: 07/09/2018
  • Issued: 05/05/2020
  • Est. Priority Date: 04/26/2016
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save
  • 0Associated
    Cases
  • 0Associated
    Defendants
  • 0Accused
    Products
  • 0Forward
    Citations
  • 0
    Petitions
  • 2
    Assignments
    ×



    ×

    Thank you for your feedback

    ×
    ×